US 9744235
Treatment of cardiovascular disorders with targeted nanoparticles
granted A61KA61K33/06A61K41/00
Quick answer
US patent 9744235 (Treatment of cardiovascular disorders with targeted nanoparticles) held by The Board of Regents of the University of Oklahoma expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K33/06, A61K41/00, A61K9/0009, A61K9/0019